Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | PGR | P06401 | 4/20 | 0.45 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.42 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.42 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.42 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16883632 | 0.78 | CYP1A2 (0.55) | CYP1A2MEN1KMT2ALMNACYP3A4 | |
| SCHEMBL6904350 | 0.76 | CYP1A2 (0.67) | CYP1A2MEN1KMT2ALMNACYP3A4 | |
| SCHEMBL12163026 | 0.75 | ALDH1A1 (0.49) | CYP1A2LMNASMN1; SMN2L3MBTL1KDM4E | |
| SCHEMBL12163032 | 0.75 | KDM4E (0.50) | CYP1A2MEN1KMT2ALMNAGRIA1 | |
| SCHEMBL612079 | 0.75 | CYP1A2 (1.00) | CYP1A2MEN1KMT2ALMNACYP3A4 | |
| SCHEMBL6909295 | 0.75 | CYP1A2 (0.65) | CYP1A2MEN1KMT2ALMNACYP3A4 | |
| SCHEMBL6799574 | 0.75 | CYP1A2 (0.65) | CYP1A2MEN1KMT2ALMNACYP3A4 | |
| SCHEMBL7063351 | 0.75 | CYP1A2 (0.65) | CYP1A2MEN1KMT2ALMNACYP3A4 | |
| SCHEMBL29701185 | 0.75 | CYP1A2 (1.00) | CYP1A2MEN1KMT2ALMNACYP3A4 | |
| SCHEMBL20656269 | 0.72 | CYP1A2 (0.51) | CYP1A2MEN1KMT2ALMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9994580-B2 | Phthalocyanine compound and method of preparing the same, color filter containing phthalocyanine compound, and coloring composition | DIC CORPORATION (JP) | 2018-06-12 | — | — | US | disclosed |
| US-9994580-B2 | Phthalocyanine compound and method of preparing the same, color filter containing phthalocyanine compound, and coloring composition | DIC CORPORATION (JP) | 2018-06-12 | — | — | US | disclosed |
| US-20170327510-A1 | PHTHALOCYANINE COMPOUND AND METHOD OF PREPARING THE SAME, COLOR FILTER CONTAINING PHTHALOCYANINE COMPOUND, AND COLORING COMPOSITION | DIC CORPORATION (JP) | 2017-11-16 | — | — | US | disclosed |
| US-20170327510-A1 | PHTHALOCYANINE COMPOUND AND METHOD OF PREPARING THE SAME, COLOR FILTER CONTAINING PHTHALOCYANINE COMPOUND, AND COLORING COMPOSITION | DIC CORPORATION (JP) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170327510-A1 | PHTHALOCYANINE COMPOUND AND METHOD OF PREPARING THE SAME, COLOR FILTER CONTAINING PHTHALOCYANINE COMPOUND, AND COLORING COMPOSITION | KMT5C, KMT5B, MAP1LC3C | CYP1A2 3911/4885MEN1 2159/4885KMT2A 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.